JP2004099447A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004099447A5 JP2004099447A5 JP2002259350A JP2002259350A JP2004099447A5 JP 2004099447 A5 JP2004099447 A5 JP 2004099447A5 JP 2002259350 A JP2002259350 A JP 2002259350A JP 2002259350 A JP2002259350 A JP 2002259350A JP 2004099447 A5 JP2004099447 A5 JP 2004099447A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- acid sequence
- amino acid
- peptide according
- terminus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 235000013305 food Nutrition 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000003674 animal food additive Substances 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 239000003638 chemical reducing agent Substances 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002259350A JP2004099447A (ja) | 2002-09-04 | 2002-09-04 | コレステロール低減化ペプチド |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002259350A JP2004099447A (ja) | 2002-09-04 | 2002-09-04 | コレステロール低減化ペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004099447A JP2004099447A (ja) | 2004-04-02 |
| JP2004099447A5 true JP2004099447A5 (https=) | 2005-09-02 |
Family
ID=32260398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002259350A Pending JP2004099447A (ja) | 2002-09-04 | 2002-09-04 | コレステロール低減化ペプチド |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2004099447A (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090104335A1 (en) * | 2006-03-24 | 2009-04-23 | Yuguang Lin | Healthy Food Product |
| EP1836906B1 (en) * | 2006-03-24 | 2009-07-01 | Unilever N.V. | Healthy food product |
| ZA200807356B (en) * | 2006-03-24 | 2009-12-30 | Unilever Plc | Healthy food product |
| WO2008056450A1 (fr) * | 2006-11-09 | 2008-05-15 | Matsumoto Institute Of Microorganisms Co., Ltd. | Agent diminuant le taux de graisse neutre dans le sang, agent augmentant le taux de cholésterol hdl et agent diminuant l'indice de rigidité artérielle |
| EP2444101A1 (en) * | 2010-10-21 | 2012-04-25 | Universitätsklinikum Freiburg | Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis |
| JP5752397B2 (ja) * | 2010-11-12 | 2015-07-22 | 三栄源エフ・エフ・アイ株式会社 | 鉄強化乳飲料用組成物 |
| CN105163748B (zh) * | 2013-02-19 | 2017-11-21 | 达能股份公司 | 用于肥胖症的功能性多肽 |
-
2002
- 2002-09-04 JP JP2002259350A patent/JP2004099447A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2455461A3 (en) | Lipase variants for pharmaceutical use | |
| Zhang et al. | Comparison of dipeptidyl peptidase IV-inhibitory activity of peptides from bovine and caprine milk casein by in silico and in vitro analyses | |
| WO2008086086A3 (en) | Glucagon analogs exhibiting enhanced solubility in physiological ph buffers | |
| JP2005516885A5 (https=) | ||
| WO2006068480A3 (en) | Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use | |
| WO2007044883A3 (en) | Improved methods and systems for tracking surgical articles | |
| JP2006521826A5 (https=) | ||
| UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
| JP2010538005A5 (https=) | ||
| WO2006117565A3 (en) | Glucagon-like-peptide-2 (glp-2) analogues | |
| WO2007056362A3 (en) | Glucagon analogs exhibiting physiological solubility and stability | |
| JP2017528419A5 (https=) | ||
| JP2012532601A5 (https=) | ||
| DE602004023210D1 (de) | Biologisch nicht-abbaubares peptid, inhibitor des angiotensinumwandelnden enzyms, arzneimittel und funktionelles nahrungsmittel | |
| NZ603811A (en) | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases | |
| WO2001083527A3 (en) | Glucagon antagonists | |
| EP2476698A3 (en) | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides | |
| WO2007128757A8 (en) | Microbial intestinal delivery of obesity related peptides | |
| WO2007076162A3 (en) | Antimicrobial cathelicidin peptides | |
| CA2507835A1 (en) | Sustained improver of muscular fatigue | |
| WO2010000801A3 (de) | Molkenproteinhydrolysate enthaltend tryptophanhaltige peptide aus alpha-lactalbumin und deren verwendung | |
| NO20042188D0 (no) | Hydrolysert marint, proteinprodukt, fremgangsmate for produksjon derav, og anvendelse | |
| EP2270035A3 (en) | Peptides enhancing CEH activity, pharmaceutical compositions comprising these peptides and their use in the treatment of atherosclerosis | |
| JP2004099447A5 (https=) | ||
| WO2000037487A8 (de) | INHIBITOREN DES INTEGRINS αvβ¿6? |